To confirm the relationship between the MAMs and lipid deposition in the kidneys of DN patients, in situ PLA was used to detect the number of MAMs by immunostaining of the ER protein (IP3R1) and mitochondrial protein (VDAC1). The gene discussed is VDAC1; the disease is liver dysplastic nodule.